Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid
Open Access
- 19 September 2007
- journal article
- review article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 299 (9), 417-422
- https://doi.org/10.1007/s00403-007-0790-5
Abstract
Bullous pemphigoid (BP) is a subepidermal skin blistering disease characterized immunohistologically by dermal-epidermal junction (DEJ) separation, an inflammatory cell infiltrate in the upper dermis, and autoantibodies targeted toward the hemidesmosomal proteins BP230 and BP180. Development of an IgG passive transfer mouse model of BP that reproduces these key features of human BP has demonstrated that subepidermal blistering is initiated by anti-BP180 antibodies and mediated by complement activation, mast cell degranulation, neutrophil infiltration, and proteinase secretion. This model is not compatible with study of human pathogenic antibodies, as the human and murine antigenic epitopes are not cross-reactive. The development of two novel humanized mouse models for the first time has enabled study of disease mechanisms caused by BP autoantibodies, and presents an ideal in vivo system to test novel therapeutic strategies for disease management.Keywords
This publication has 65 references indexed in Scilit:
- A Pathogenic Role for IgE in Autoimmunity: Bullous Pemphigoid IgE Reproduces the Early Phase of Lesion Development in Human Skin Grafted to nu/nu MiceJournal of Investigative Dermatology, 2007
- IgE Basement Membrane Zone Antibodies Induce Eosinophil Infiltration and Histological Blisters in Engrafted Human Skin on SCID MiceJournal of Investigative Dermatology, 2007
- Role of different pathways of the complement cascade in experimental bullous pemphigoidJCI Insight, 2006
- Respective Contribution of Neutrophil Elastase and Matrix Metalloproteinase 9 in the Degradation of BP180 (Type XVII Collagen) in Human Bullous PemphigoidJournal of Investigative Dermatology, 2001
- IgG4 and IgE are the major immunoglobulins targeting the NC 16A domain of BP 180 in bullous pemphigoid: Serum levels of these immunoglobulins reflect disease activityJournal of the American Academy of Dermatology, 2000
- Gelatinase B–deficient Mice Are Resistant to Experimental Bullous PemphigoidThe Journal of Experimental Medicine, 1998
- Elevated levels of interleukin-8 in blister fluid of bullous pemphigoidcompared with suction blisters of healthy control subjectsJournal of the American Academy of Dermatology, 1996
- Granulocyte activation in bullous diseases: Release of granular proteins in bullous pemphigoid and pemphigus vulgarisJournal of the American Academy of Dermatology, 1993
- Production of Rabbit Antibodies Against Carboxy-Terminal Epitopes Encoded by Bullous Pemphigoid cDNAJournal of Investigative Dermatology, 1990
- Morphologic and Functional Evidence for Release of Mast-Cell Products in Bullous PemphigoidNew England Journal of Medicine, 1978